New perspectives in keratoconus treatment : an update on iontophoresis-assisted corneal collagen crosslinking

Keratoconus is a bilateral, asymmetric and progressive corneal disease. It usually results in apical thinning and steepening with corneal deformation and impaired vision. Since the early 1990 s, corneal collagen crosslinking (CXL) has remained the primary treatment to stabilize the progression of the disease. Iontophoresis-assisted CXL (I-CXL) has been proposed as a non-invasive alternative to standard epithelium-off technique, showing promising results. In this article, we review up to date literature to provide state of art knowledge and future perspectives of I-CXL.

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:41

Enthalten in:

International ophthalmology - 41(2021), 5 vom: 15. Mai, Seite 1909-1916

Sprache:

Englisch

Beteiligte Personen:

Vinciguerra, Paolo [VerfasserIn]
Montericcio, Alessio [VerfasserIn]
Catania, Fiammetta [VerfasserIn]
Fossati, Giovanni [VerfasserIn]
Raimondi, Raffaele [VerfasserIn]
Legrottaglie, Emanuela Filomena [VerfasserIn]
Vinciguerra, Riccardo [VerfasserIn]

Links:

Volltext

Themen:

9007-34-5
Collagen
Cross-Linking Reagents
Crosslinking
Iontophoresis
Journal Article
Keratoconus
Photosensitizing Agents
Review
Riboflavin
TLM2976OFR

Anmerkungen:

Date Completed 18.06.2021

Date Revised 18.06.2021

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1007/s10792-021-01713-4

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM321494415